Skip to main content
Top
Published in: Virology Journal 1/2010

Open Access 01-12-2010 | Research

Detection of hepatitis B virus DNA among accepted blood donors in Nanjing, China

Authors: Yong Liu, Ping Li, Cuiping Li, Jinyong Zhou, Chao Wu, Yi-Hua Zhou

Published in: Virology Journal | Issue 1/2010

Login to get access

Abstract

Background

Posttransfusion hepatitis B virus (HBV) infection still occurs although its incidence has been substantially reduced since the introduction of screening of hepatitis B surface antigen (HBsAg) in blood donors. This study aimed to investigate the occult HBV infection in accepted blood donors in Nanjing, China.

Results

The lower detection limit of the nested PCR in this study was estimated to be 20 copies/ml HBV DNA. The positive rate of occult HBV infection was 0.13% (5 of 2972) in the accepted blood donors. Sequencing data showed that the amplified HBV sequences were not identical each other and to the known sequences cloned in our laboratory, excluding the false-positive caused by cross-contamination. Phylogenetic analysis showed that the HBV in all five donors was genotype B; a single base deletion was detected in the S region of HBV DNA from one donor, and no mutation was observed in the "a" determinant of HBsAg from four other donors. All five donors were negative for anti-HBs and one was positive for anti-HBc.

Conclusions

The prevalence of occult HBV infection in the accepted blood donors in Nanjing, China is relatively high. The data would be meaningful in adapting strategy to eliminate posttransfusion HBV infection in China.
Appendix
Available only for authorised users
Literature
1.
go back to reference Gerlich WH, Bremer C, Saniewski M, Schuttler CG, Wend UC, Willems WR, Glebe D: Occult hepatitis B virus infection: detection and significance. Digest Dis 2010, 28: 116-125. 10.1159/000282074CrossRef Gerlich WH, Bremer C, Saniewski M, Schuttler CG, Wend UC, Willems WR, Glebe D: Occult hepatitis B virus infection: detection and significance. Digest Dis 2010, 28: 116-125. 10.1159/000282074CrossRef
2.
go back to reference Raimondo G, Allain JP, Brunetto MR, Buendia MA, Chen DS, Colombo M, Craxi A, Donato F, Ferrari C, Gaeta GB, Gerlich WH, Levrero M, Locarnini S, Michalak T, Mondelli MU, Pawlotsky JM, Pollicino T, Prati D, Puoti M, Samuel D, Shouval D, Smedile A, Squadrito G, Trepo C, Villa E, Will H, Zanetti AR, Zoulim F: Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol 2008, 49: 652-657. 10.1016/j.jhep.2008.07.014PubMedCrossRef Raimondo G, Allain JP, Brunetto MR, Buendia MA, Chen DS, Colombo M, Craxi A, Donato F, Ferrari C, Gaeta GB, Gerlich WH, Levrero M, Locarnini S, Michalak T, Mondelli MU, Pawlotsky JM, Pollicino T, Prati D, Puoti M, Samuel D, Shouval D, Smedile A, Squadrito G, Trepo C, Villa E, Will H, Zanetti AR, Zoulim F: Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol 2008, 49: 652-657. 10.1016/j.jhep.2008.07.014PubMedCrossRef
3.
go back to reference Zhang R, Wang L, Li J: Hepatitis B virus transfusion risk in China: proficiency testing for the detection of hepatitis B surface antigen. Transfusion Med 2010, in press. Zhang R, Wang L, Li J: Hepatitis B virus transfusion risk in China: proficiency testing for the detection of hepatitis B surface antigen. Transfusion Med 2010, in press.
4.
go back to reference Niederhauser C, Mansouri Taleghani B, Graziani M, Stolz M, Tinguely C, Schneider P: Blood donor screening: how to decrease the risk of transfusion-transmitted hepatitis B virus? Swiss Med Wkly 2008, 138: 134-141.PubMed Niederhauser C, Mansouri Taleghani B, Graziani M, Stolz M, Tinguely C, Schneider P: Blood donor screening: how to decrease the risk of transfusion-transmitted hepatitis B virus? Swiss Med Wkly 2008, 138: 134-141.PubMed
5.
go back to reference Calderon GM, Gonzalez-Velazquez F, Gonzalez-Bonilla CR, Novelo-Garza B, Terrazas JJ, Martinez-Rodriguez ML, Cortes-Marquez SR, Blanco-Flores JP, Rodriguez-Rodriguez A, Del Campo MA, Cortes-Gomez R, Mejia-Bocanegra MG: Prevalence and risk factors of hepatitis C virus, hepatitis B virus, and human immunodeficiency virus in multiply transfused recipients in Mexico. Transfusion 2009, 49: 2200-2207. 10.1111/j.1537-2995.2009.02248.xPubMedCrossRef Calderon GM, Gonzalez-Velazquez F, Gonzalez-Bonilla CR, Novelo-Garza B, Terrazas JJ, Martinez-Rodriguez ML, Cortes-Marquez SR, Blanco-Flores JP, Rodriguez-Rodriguez A, Del Campo MA, Cortes-Gomez R, Mejia-Bocanegra MG: Prevalence and risk factors of hepatitis C virus, hepatitis B virus, and human immunodeficiency virus in multiply transfused recipients in Mexico. Transfusion 2009, 49: 2200-2207. 10.1111/j.1537-2995.2009.02248.xPubMedCrossRef
6.
go back to reference Kafi-abad SA, Rezvan H, Abolghasemi H, Talebian A: Prevalence and trends of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among blood donors in Iran, 2004 through 2007. Transfusion 2009, 49: 2214-2220. 10.1111/j.1537-2995.2009.02245.xPubMedCrossRef Kafi-abad SA, Rezvan H, Abolghasemi H, Talebian A: Prevalence and trends of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among blood donors in Iran, 2004 through 2007. Transfusion 2009, 49: 2214-2220. 10.1111/j.1537-2995.2009.02245.xPubMedCrossRef
7.
go back to reference Hollinger FB: Hepatitis B virus infection and transfusion medicine: science and the occult. Transfusion 2008, 48: 1001-1026. 10.1111/j.1537-2995.2008.01701.xPubMedCrossRef Hollinger FB: Hepatitis B virus infection and transfusion medicine: science and the occult. Transfusion 2008, 48: 1001-1026. 10.1111/j.1537-2995.2008.01701.xPubMedCrossRef
8.
go back to reference Giudice CL, Martinengo M, Pietrasanta P, Bocciardo L, Malavasi C, Rastelli S, Faraci M, Tripodi G: Occult hepatitis B virus infection: a case of reactivation in a patient receiving immunosuppressive treatment for allogeneic bone marrow transplantation. Blood transfus 2008, 6: 46-50.PubMedPubMedCentral Giudice CL, Martinengo M, Pietrasanta P, Bocciardo L, Malavasi C, Rastelli S, Faraci M, Tripodi G: Occult hepatitis B virus infection: a case of reactivation in a patient receiving immunosuppressive treatment for allogeneic bone marrow transplantation. Blood transfus 2008, 6: 46-50.PubMedPubMedCentral
9.
go back to reference Raimondo G, Pollicino T, Romano L, Zanetti AR: A 2010 update on occult hepatitis B infection. Pathol Biol 2010, 58: 254-257. 10.1016/j.patbio.2010.02.003PubMedCrossRef Raimondo G, Pollicino T, Romano L, Zanetti AR: A 2010 update on occult hepatitis B infection. Pathol Biol 2010, 58: 254-257. 10.1016/j.patbio.2010.02.003PubMedCrossRef
10.
go back to reference Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, Zhang Y, Liu J, Gong X, Chen Y, Wang F, Zheng H, Wang F, Guo J, Jia Z, Ma J, Wang H, Luo H, Li L, Jin S, Hadler SC, Wang Y: Epidemiological serosurvey of hepatitis B in China--declining HBV prevalence due to hepatitis B vaccination. Vaccine 2009, 27: 6550-6557. 10.1016/j.vaccine.2009.08.048PubMedCrossRef Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, Zhang Y, Liu J, Gong X, Chen Y, Wang F, Zheng H, Wang F, Guo J, Jia Z, Ma J, Wang H, Luo H, Li L, Jin S, Hadler SC, Wang Y: Epidemiological serosurvey of hepatitis B in China--declining HBV prevalence due to hepatitis B vaccination. Vaccine 2009, 27: 6550-6557. 10.1016/j.vaccine.2009.08.048PubMedCrossRef
11.
go back to reference Zhou YH, Wu C, Zhuang H: Vaccination against hepatitis B: the Chinese experience. Chin Med J (Engl) 2009, 122: 98-102. Zhou YH, Wu C, Zhuang H: Vaccination against hepatitis B: the Chinese experience. Chin Med J (Engl) 2009, 122: 98-102.
12.
go back to reference Zhang S, Li RT, Wang Y, Liu Q, Zhou YH, Hu Y: Seroprevalence of hepatitis B surface antigen among pregnant women in Jiangsu, China, 17 years after introduction of hepatitis B vaccine. Int J Gynecol Obstet 2010, 109: 194-197. 10.1016/j.ijgo.2010.01.002CrossRef Zhang S, Li RT, Wang Y, Liu Q, Zhou YH, Hu Y: Seroprevalence of hepatitis B surface antigen among pregnant women in Jiangsu, China, 17 years after introduction of hepatitis B vaccine. Int J Gynecol Obstet 2010, 109: 194-197. 10.1016/j.ijgo.2010.01.002CrossRef
13.
go back to reference Brechot C, Thiers V, Kremsdorf D, Nalpas B, Pol S, Paterlini-Brechot P: Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely "occult"? Hepatology 2001, 34: 194-203. 10.1053/jhep.2001.25172PubMedCrossRef Brechot C, Thiers V, Kremsdorf D, Nalpas B, Pol S, Paterlini-Brechot P: Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely "occult"? Hepatology 2001, 34: 194-203. 10.1053/jhep.2001.25172PubMedCrossRef
14.
go back to reference Zervou EK, Dalekos GN, Boumba DS, Tsianos EV: Value of anti-HBc screening of blood donors for prevention of HBV infection: results of a 3-year prospective study in Northwestern Greece. Transfusion 2001, 41: 652-658. 10.1046/j.1537-2995.2001.41050652.xPubMedCrossRef Zervou EK, Dalekos GN, Boumba DS, Tsianos EV: Value of anti-HBc screening of blood donors for prevention of HBV infection: results of a 3-year prospective study in Northwestern Greece. Transfusion 2001, 41: 652-658. 10.1046/j.1537-2995.2001.41050652.xPubMedCrossRef
15.
go back to reference Shang G, Seed CR, Wang F, Nie D, Farrugia A: Residual risk of transfusion-transmitted viral infections in Shenzhen, China, 2001 through 2004. Transfusion 2007, 47: 529-539. 10.1111/j.1537-2995.2006.01146.xPubMedCrossRef Shang G, Seed CR, Wang F, Nie D, Farrugia A: Residual risk of transfusion-transmitted viral infections in Shenzhen, China, 2001 through 2004. Transfusion 2007, 47: 529-539. 10.1111/j.1537-2995.2006.01146.xPubMedCrossRef
16.
go back to reference Fang Y, Shang QL, Liu JY, Li D, Xu WZ, Teng X, Zhao HW, Fu LJ, Zhang FM, Gu HX: Prevalence of occult hepatitis B virus infection among hepatopathy patients and healthy people in China. J Infect 2009, 58: 383-388. 10.1016/j.jinf.2009.02.013PubMedCrossRef Fang Y, Shang QL, Liu JY, Li D, Xu WZ, Teng X, Zhao HW, Fu LJ, Zhang FM, Gu HX: Prevalence of occult hepatitis B virus infection among hepatopathy patients and healthy people in China. J Infect 2009, 58: 383-388. 10.1016/j.jinf.2009.02.013PubMedCrossRef
17.
go back to reference Shang G, Yan Y, Yang B, Shao C, Wang F, Li Q, Seed CR: Two HBV DNA+/HBsAg-blood donors identified by HBV NAT in Shenzhen, China. Transfus Apher Sci 2009, 41: 3-7. 10.1016/j.transci.2009.05.001PubMedCrossRef Shang G, Yan Y, Yang B, Shao C, Wang F, Li Q, Seed CR: Two HBV DNA+/HBsAg-blood donors identified by HBV NAT in Shenzhen, China. Transfus Apher Sci 2009, 41: 3-7. 10.1016/j.transci.2009.05.001PubMedCrossRef
18.
go back to reference Bamaga MS, Azahar EI, Al-Ghamdi AK, Al-Enzi FQ, Farahat FM: Nucleic acid amplification technology for hepatitis B virus, and its role in blood donation screening in blood banks. Saudi Med J 2009, 30: 1416-1421.PubMed Bamaga MS, Azahar EI, Al-Ghamdi AK, Al-Enzi FQ, Farahat FM: Nucleic acid amplification technology for hepatitis B virus, and its role in blood donation screening in blood banks. Saudi Med J 2009, 30: 1416-1421.PubMed
19.
go back to reference Gonzalez R, Torres P, Castro E, Barbolla L, Candotti D, Koppelman M, Zaaijer HL, Lelie N, Allain JP, Echevarria JM: Efficacy of hepatitis B virus (HBV) DNA screening and characterization of acute and occult HBV infections among blood donors from Madrid, Spain. Transfusion 2009, 50: 221-230. 10.1111/j.1537-2995.2009.02343.xPubMedCrossRef Gonzalez R, Torres P, Castro E, Barbolla L, Candotti D, Koppelman M, Zaaijer HL, Lelie N, Allain JP, Echevarria JM: Efficacy of hepatitis B virus (HBV) DNA screening and characterization of acute and occult HBV infections among blood donors from Madrid, Spain. Transfusion 2009, 50: 221-230. 10.1111/j.1537-2995.2009.02343.xPubMedCrossRef
20.
21.
go back to reference Raimondo G, Pollicino T, Cacciola I, Squadrito G: Occult hepatitis B virus infection. J Hepatol 2007, 46: 160-170. 10.1016/j.jhep.2006.10.007PubMedCrossRef Raimondo G, Pollicino T, Cacciola I, Squadrito G: Occult hepatitis B virus infection. J Hepatol 2007, 46: 160-170. 10.1016/j.jhep.2006.10.007PubMedCrossRef
22.
go back to reference Lelie N, Heaton A: Hepatitis B - a review of the role of NAT in enhancing blood safety. J Clin Virol 2006,36(Suppl 1):S1-2. 10.1016/S1386-6532(06)80001-6PubMedCrossRef Lelie N, Heaton A: Hepatitis B - a review of the role of NAT in enhancing blood safety. J Clin Virol 2006,36(Suppl 1):S1-2. 10.1016/S1386-6532(06)80001-6PubMedCrossRef
23.
go back to reference Offergeld R, Faensen D, Ritter S, Hamouda O: Human immunodeficiency virus, hepatitis C and hepatitis B infections among blood donors in Germany 2000-2002: risk of virus transmission and the impact of nucleic acid amplification testing. Euro Surveill 2005, 10: 8-11.PubMed Offergeld R, Faensen D, Ritter S, Hamouda O: Human immunodeficiency virus, hepatitis C and hepatitis B infections among blood donors in Germany 2000-2002: risk of virus transmission and the impact of nucleic acid amplification testing. Euro Surveill 2005, 10: 8-11.PubMed
24.
go back to reference Chevrier MC, St-Louis M, Perreault J, Caron B, Castilloux C, Laroche J, Delage G: Detection and characterization of hepatitis B virus of anti-hepatitis B core antigen-reactive blood donors in Quebec with an in-house nucleic acid testing assay. Transfusion 2007, 47: 1794-1802. 10.1111/j.1537-2995.2007.01394.xPubMedCrossRef Chevrier MC, St-Louis M, Perreault J, Caron B, Castilloux C, Laroche J, Delage G: Detection and characterization of hepatitis B virus of anti-hepatitis B core antigen-reactive blood donors in Quebec with an in-house nucleic acid testing assay. Transfusion 2007, 47: 1794-1802. 10.1111/j.1537-2995.2007.01394.xPubMedCrossRef
25.
go back to reference Owusu-Ofori S, Temple J, Sarkodie F, Anokwa M, Candotti D, Allain JP: Predonation screening of blood donors with rapid tests: implementation and efficacy of a novel approach to blood safety in resource-poor settings. Transfusion 2005, 45: 133-140. 10.1111/j.1537-2995.2004.04279.xPubMedCrossRef Owusu-Ofori S, Temple J, Sarkodie F, Anokwa M, Candotti D, Allain JP: Predonation screening of blood donors with rapid tests: implementation and efficacy of a novel approach to blood safety in resource-poor settings. Transfusion 2005, 45: 133-140. 10.1111/j.1537-2995.2004.04279.xPubMedCrossRef
26.
go back to reference Wang DW, Wang TB, Liu FP, Shi LL: Study about seroconversion of HBV NAT screening-positive crowd from blood donors. Chinese Journal of Experimental and Clinical Virology 2008, 22: 127-129.PubMed Wang DW, Wang TB, Liu FP, Shi LL: Study about seroconversion of HBV NAT screening-positive crowd from blood donors. Chinese Journal of Experimental and Clinical Virology 2008, 22: 127-129.PubMed
27.
go back to reference Chen BY, Shen J: HBV-DNA detection in HBsAg negative blood donors and its clinical significance. Chinese Journal of Nosocomiology 2007, 10: 1240-1241. Chen BY, Shen J: HBV-DNA detection in HBsAg negative blood donors and its clinical significance. Chinese Journal of Nosocomiology 2007, 10: 1240-1241.
28.
go back to reference Wang D, Tan D, Cao X: A prospective study of posttransfusion hepatitis B virus infection. Chinese Journal of Experimental and Clinical Virology 2000, 14: 77-79.PubMed Wang D, Tan D, Cao X: A prospective study of posttransfusion hepatitis B virus infection. Chinese Journal of Experimental and Clinical Virology 2000, 14: 77-79.PubMed
29.
go back to reference Kreutz C: Molecular, immunological and clinical properties of mutated hepatitis B viruses. J Cell Mol Med 2002, 6: 113-143. 10.1111/j.1582-4934.2002.tb00317.xPubMedCrossRef Kreutz C: Molecular, immunological and clinical properties of mutated hepatitis B viruses. J Cell Mol Med 2002, 6: 113-143. 10.1111/j.1582-4934.2002.tb00317.xPubMedCrossRef
30.
go back to reference Laulu SL, Roberts WL: The analytic sensitivity and mutant detection capability of six hepatitis B surface antigen assays. Am J Clin Pathol 2006, 125: 748-751. 10.1309/K5EM795VNGGFGBXXCrossRef Laulu SL, Roberts WL: The analytic sensitivity and mutant detection capability of six hepatitis B surface antigen assays. Am J Clin Pathol 2006, 125: 748-751. 10.1309/K5EM795VNGGFGBXXCrossRef
31.
go back to reference Weber B: Diagnostic impact of the genetic variability of the hepatitis B virus surface antigen gene. J Med Virol 2006,78(Suppl 1):S59-65. 10.1002/jmv.20610PubMedCrossRef Weber B: Diagnostic impact of the genetic variability of the hepatitis B virus surface antigen gene. J Med Virol 2006,78(Suppl 1):S59-65. 10.1002/jmv.20610PubMedCrossRef
32.
go back to reference Hollinger FB: Hepatitis B virus genetic diversity and its impact on diagnostic assays. J Viral Hepat 2007,14(Suppl 1):S11-15. 10.1111/j.1365-2893.2007.00910.xCrossRef Hollinger FB: Hepatitis B virus genetic diversity and its impact on diagnostic assays. J Viral Hepat 2007,14(Suppl 1):S11-15. 10.1111/j.1365-2893.2007.00910.xCrossRef
33.
go back to reference Chemin I, Trepo C: Clinical impact of occult HBV infections. J Clin Virol 2005,34(Suppl 1):S15-21. 10.1016/S1386-6532(05)80005-8PubMedCrossRef Chemin I, Trepo C: Clinical impact of occult HBV infections. J Clin Virol 2005,34(Suppl 1):S15-21. 10.1016/S1386-6532(05)80005-8PubMedCrossRef
34.
go back to reference Gerlich WH, Glebe D, Schuttler CG: Deficiencies in the standardization and sensitivity of diagnostic tests for hepatitis B virus. J Viral Hepat 2007,14(Suppl 1):16-21. 10.1111/j.1365-2893.2007.00912.xPubMedCrossRef Gerlich WH, Glebe D, Schuttler CG: Deficiencies in the standardization and sensitivity of diagnostic tests for hepatitis B virus. J Viral Hepat 2007,14(Suppl 1):16-21. 10.1111/j.1365-2893.2007.00912.xPubMedCrossRef
35.
go back to reference Hollinger FB, Sood G: Occult hepatitis B virus infection: a covert operation. J Viral Hepat 2010, 17: 1-15. 10.1111/j.1365-2893.2009.01245.xPubMedCrossRef Hollinger FB, Sood G: Occult hepatitis B virus infection: a covert operation. J Viral Hepat 2010, 17: 1-15. 10.1111/j.1365-2893.2009.01245.xPubMedCrossRef
36.
go back to reference Zerbini A, Pilli M, Boni C, Fisicaro P, Penna A, Di Vincenzo P, Giuberti T, Orlandini A, Raffa G, Pollicino T, Raimondo G, Ferrari C, Missale G: The characteristics of the cell-mediated immune response identify different profiles of occult hepatitis B virus infection. Gastroenterology 2008, 134: 1470-1481. 10.1053/j.gastro.2008.02.017PubMedCrossRef Zerbini A, Pilli M, Boni C, Fisicaro P, Penna A, Di Vincenzo P, Giuberti T, Orlandini A, Raffa G, Pollicino T, Raimondo G, Ferrari C, Missale G: The characteristics of the cell-mediated immune response identify different profiles of occult hepatitis B virus infection. Gastroenterology 2008, 134: 1470-1481. 10.1053/j.gastro.2008.02.017PubMedCrossRef
37.
go back to reference Torbenson M, Thomas DL: Occult hepatitis B. Lancet Infect Dis 2002, 2: 479-486. 10.1016/S1473-3099(02)00345-6PubMedCrossRef Torbenson M, Thomas DL: Occult hepatitis B. Lancet Infect Dis 2002, 2: 479-486. 10.1016/S1473-3099(02)00345-6PubMedCrossRef
38.
go back to reference Komiya Y, Katayama K, Yugi H, Mizui M, Matsukura H, Tomoguri T, Miyakawa Y, Tabuchi A, Tanaka J, Yoshizawa H: Minimum infectious dose of hepatitis B virus in chimpanzees and difference in the dynamics of viremia between genotype A and genotype C. Transfusion 2008, 48: 286-294.PubMed Komiya Y, Katayama K, Yugi H, Mizui M, Matsukura H, Tomoguri T, Miyakawa Y, Tabuchi A, Tanaka J, Yoshizawa H: Minimum infectious dose of hepatitis B virus in chimpanzees and difference in the dynamics of viremia between genotype A and genotype C. Transfusion 2008, 48: 286-294.PubMed
39.
go back to reference Candotti D, Allain JP: Transfusion-transmitted hepatitis B virus infection. J Hepatol 2009, 51: 798-809. 10.1016/j.jhep.2009.05.020PubMedCrossRef Candotti D, Allain JP: Transfusion-transmitted hepatitis B virus infection. J Hepatol 2009, 51: 798-809. 10.1016/j.jhep.2009.05.020PubMedCrossRef
40.
go back to reference Hoofnagle JH, Waggoner JG: Hepatitis A and B virus markers in immune serum globulin. Gastroenterology 1980, 78: 259-263.PubMed Hoofnagle JH, Waggoner JG: Hepatitis A and B virus markers in immune serum globulin. Gastroenterology 1980, 78: 259-263.PubMed
41.
go back to reference Levicnik-Stezinar S, Rahne-Potokar U, Candotti D, Lelie N, Allain JP: Anti-HBs positive occult hepatitis B virus carrier blood infectious in two transfusion recipients. J Hepatol 2008, 48: 1022-1025. 10.1016/j.jhep.2008.02.016PubMedCrossRef Levicnik-Stezinar S, Rahne-Potokar U, Candotti D, Lelie N, Allain JP: Anti-HBs positive occult hepatitis B virus carrier blood infectious in two transfusion recipients. J Hepatol 2008, 48: 1022-1025. 10.1016/j.jhep.2008.02.016PubMedCrossRef
42.
go back to reference Wendel S, Levi JE, Biagini S, Candotti D, Allain JP: A probable case of hepatitis B virus transfusion transmission revealed after a 13-month-long window period. Transfusion 2008, 48: 1602-1608. 10.1111/j.1537-2995.2008.01723.xPubMedCrossRef Wendel S, Levi JE, Biagini S, Candotti D, Allain JP: A probable case of hepatitis B virus transfusion transmission revealed after a 13-month-long window period. Transfusion 2008, 48: 1602-1608. 10.1111/j.1537-2995.2008.01723.xPubMedCrossRef
43.
go back to reference Jackson BR, Busch MP, Stramer SL, AuBuchon JP: The cost-effectiveness of NAT for HIV, HCV, and HBV in whole-blood donations. Transfusion 2003, 43: 721-729. 10.1046/j.1537-2995.2003.00392.xPubMedCrossRef Jackson BR, Busch MP, Stramer SL, AuBuchon JP: The cost-effectiveness of NAT for HIV, HCV, and HBV in whole-blood donations. Transfusion 2003, 43: 721-729. 10.1046/j.1537-2995.2003.00392.xPubMedCrossRef
44.
go back to reference Toyoda H, Hayashi K, Murakami Y, Honda T, Katano Y, Nakano I, Goto H, Kumada T, Takamatsu J: Prevalence and clinical implications of occult hepatitis B viral infection in hemophilia patients in Japan. J Med Virol 2004, 73: 195-199. 10.1002/jmv.20075PubMedCrossRef Toyoda H, Hayashi K, Murakami Y, Honda T, Katano Y, Nakano I, Goto H, Kumada T, Takamatsu J: Prevalence and clinical implications of occult hepatitis B viral infection in hemophilia patients in Japan. J Med Virol 2004, 73: 195-199. 10.1002/jmv.20075PubMedCrossRef
45.
go back to reference Hui CK, Sun J, Au WY, Lie AK, Yueng YH, Zhang HY, Lee NP, Hou JL, Liang R, Lau GK: Occult hepatitis B virus infection in hematopoietic stem cell donors in a hepatitis B virus endemic area. J Hepatol 2005, 42: 813-819. 10.1016/j.jhep.2005.01.018PubMedCrossRef Hui CK, Sun J, Au WY, Lie AK, Yueng YH, Zhang HY, Lee NP, Hou JL, Liang R, Lau GK: Occult hepatitis B virus infection in hematopoietic stem cell donors in a hepatitis B virus endemic area. J Hepatol 2005, 42: 813-819. 10.1016/j.jhep.2005.01.018PubMedCrossRef
46.
go back to reference Kim SM, Lee KS, Park CJ, Lee JY, Kim KH, Park JY, Lee JH, Kim HY, Yoo JY, Jang MK: Prevalence of occult HBV infection among subjects with normal serum ALT levels in Korea. J Infect 2007, 54: 185-191. 10.1016/j.jinf.2006.02.002PubMedCrossRef Kim SM, Lee KS, Park CJ, Lee JY, Kim KH, Park JY, Lee JH, Kim HY, Yoo JY, Jang MK: Prevalence of occult HBV infection among subjects with normal serum ALT levels in Korea. J Infect 2007, 54: 185-191. 10.1016/j.jinf.2006.02.002PubMedCrossRef
47.
go back to reference Utama A, Octavia TI, Dhenni R, Miskad UA, Yusuf I, Tai S: Hepatitis B virus genotypes/subgenotypes in voluntary blood donors in Makassar, South Sulawesi, Indonesia. Virol J 2009, 6: 128. 10.1186/1743-422X-6-128PubMedPubMedCentralCrossRef Utama A, Octavia TI, Dhenni R, Miskad UA, Yusuf I, Tai S: Hepatitis B virus genotypes/subgenotypes in voluntary blood donors in Makassar, South Sulawesi, Indonesia. Virol J 2009, 6: 128. 10.1186/1743-422X-6-128PubMedPubMedCentralCrossRef
Metadata
Title
Detection of hepatitis B virus DNA among accepted blood donors in Nanjing, China
Authors
Yong Liu
Ping Li
Cuiping Li
Jinyong Zhou
Chao Wu
Yi-Hua Zhou
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2010
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/1743-422X-7-193

Other articles of this Issue 1/2010

Virology Journal 1/2010 Go to the issue